AU2002352221A1 - Bicyclic n-arylamides - Google Patents

Bicyclic n-arylamides

Info

Publication number
AU2002352221A1
AU2002352221A1 AU2002352221A AU2002352221A AU2002352221A1 AU 2002352221 A1 AU2002352221 A1 AU 2002352221A1 AU 2002352221 A AU2002352221 A AU 2002352221A AU 2002352221 A AU2002352221 A AU 2002352221A AU 2002352221 A1 AU2002352221 A1 AU 2002352221A1
Authority
AU
Australia
Prior art keywords
arylamides
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352221A
Other languages
English (en)
Inventor
Frank-Gerhard Boss
Christina Erb
Timo Flessner
Martin Hendrix
Joachim Luithle
Christoph Methfessel
Marja Van Kampen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002352221A1 publication Critical patent/AU2002352221A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002352221A 2001-12-19 2002-12-06 Bicyclic n-arylamides Abandoned AU2002352221A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10162375.5 2001-12-19
DE10162375A DE10162375A1 (de) 2001-12-19 2001-12-19 Bicyclische N-Aryl-amide
PCT/EP2002/013835 WO2003051874A1 (de) 2001-12-19 2002-12-06 Bicyclische n-arylamide

Publications (1)

Publication Number Publication Date
AU2002352221A1 true AU2002352221A1 (en) 2003-06-30

Family

ID=7709793

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352221A Abandoned AU2002352221A1 (en) 2001-12-19 2002-12-06 Bicyclic n-arylamides

Country Status (8)

Country Link
US (1) US7247728B2 (https=)
EP (1) EP1458716B1 (https=)
JP (1) JP4690651B2 (https=)
AU (1) AU2002352221A1 (https=)
CA (1) CA2470726C (https=)
DE (2) DE10162375A1 (https=)
ES (1) ES2274114T3 (https=)
WO (1) WO2003051874A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
MXPA05003317A (es) * 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
US20040157626A1 (en) * 2003-02-10 2004-08-12 Vincent Park Paging methods and apparatus
US7434145B2 (en) * 2003-04-02 2008-10-07 Qualcomm Incorporated Extracting soft information in a block-coherent communication system
US8196000B2 (en) * 2003-04-02 2012-06-05 Qualcomm Incorporated Methods and apparatus for interleaving in a block-coherent communication system
DE10334724A1 (de) * 2003-07-30 2005-02-24 Bayer Healthcare Ag N-Biarylamide
DE602004010299T2 (de) 2003-12-22 2008-09-18 Memory Pharmaceuticals Corp. Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
US7423164B2 (en) 2003-12-31 2008-09-09 Ut-Battelle, Llc Synthesis of ionic liquids
NZ550534A (en) 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
WO2006001894A1 (en) 2004-04-22 2006-01-05 Memory Pharmaceutical Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
JP2007538011A (ja) * 2004-05-07 2007-12-27 メモリー・ファーマシューティカルズ・コーポレイション １ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
RU2418797C2 (ru) 2004-12-22 2011-05-20 Мемори Фармасьютиклз Корпорейшн Лиганды никотинового рецептора альфа-7, их получение и применение
AU2006295397A1 (en) * 2005-09-23 2007-04-05 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
KR20180011888A (ko) 2008-11-19 2018-02-02 포럼 파마슈티칼즈 인크. (ｒ)-７-클로로-ｎ-(퀴누클리딘-３-일)벤조［ｂ］티오펜-２-카르복사미드 및 그 약학적으로 허용가능한 염을 이용한 인지 장애의 치료
PE20120324A1 (es) * 2009-05-11 2012-04-17 Envivo Pharmaceuticals Inc Combinacion que comprende (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y donezepilo como moduladora de trastornos cognitivos
AR081402A1 (es) 2010-05-17 2012-08-29 Envivo Pharmaceuticals Inc Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
JP2017518348A (ja) * 2014-06-20 2017-07-06 オーリジーン ディスカバリー テクノロジーズ リミテッドＡｕｒｉｇｅｎｅ Ｄｉｓｃｏｖｅｒｙ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｉｍｉｔｅｄ Ｉｒａｋ４阻害剤としての置換インダゾール化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
CA2413683A1 (en) * 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Fused cyclic compounds as modulators of nuclear hormone receptor function
DE20013068U1 (de) * 2000-07-27 2001-11-29 AUTEFA Automation GmbH, 86316 Friedberg Fördereinrichtung für Kannen in einem Kannenlager

Also Published As

Publication number Publication date
JP4690651B2 (ja) 2011-06-01
DE50208287D1 (de) 2006-11-09
DE10162375A1 (de) 2003-07-10
EP1458716A1 (de) 2004-09-22
US20050107460A1 (en) 2005-05-19
WO2003051874A1 (de) 2003-06-26
ES2274114T3 (es) 2007-05-16
US7247728B2 (en) 2007-07-24
CA2470726A1 (en) 2003-06-26
CA2470726C (en) 2012-01-31
JP2005517657A (ja) 2005-06-16
EP1458716B1 (de) 2006-09-27

Similar Documents

Publication Publication Date Title
AU2002313565A1 (en) Putter-heads
AU2002352221A1 (en) Bicyclic n-arylamides
AU2002336311A1 (en) Bicyclic compound
AU2002308154A1 (en) Triazolopyrimidines
AU2002364901A1 (en) Object decontaminator
AU2002319532A1 (en) Feeding-bottles
AU2002330025A1 (en) Atlastin
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
AU2001100214A4 (en) Dolly-trolley
AU2001100532A4 (en) FonePark
AU2001100522A4 (en) e-Trans
AU2001100338A4 (en) Sunglove
AU2002100746A4 (en) Adrail
AU2002302546A1 (en) Fitting
AU2002304671A1 (en) Triazolopyrimidines
AU2002357687A1 (en) Pyrazolopyrimidines
AU2002253687A1 (en) Floss-pick
AU2002302413A1 (en) Tryptase-inhibitors
AU2002328106A1 (en) Mcraly-coating
AU2002249693A1 (en) Starseparator
AU2002235675A1 (en) Regakine-1

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase